Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn about the safety and effectiveness of ENV-294 in adults with moderate to severe atopic dermatitis. The main questions it will answer are: * Is there an im...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Enveda Therapeutics
NCT06928246 · Atopic Dermatitis (AD)
NCT07316465 · Atopic Dermatitis (AD), Autoantibody, and more
NCT07235384 · Atopic Dermatitis (AD)
NCT06982352 · Atopic Dermatitis (AD), Psoriasis (PsO)
NCT07259343 · Atopic Dermatitis (AD)
Enveda Investigative Site
Birmingham, Alabama
Enveda Investigative Site
Hot Springs, Arkansas
Enveda Investigative Site
Fremont, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions